• Syrian healthtech startup Alo Hakeem has raised $165,000 in a pre-seed funding round led by EBLA Ventures, with participation from other undisclosed investors.
• Founded in 2025 by Abdullatif Al-Baroudi and Albaraa Abdulsalam, Alo Hakeem operates a digital platform connecting patients with licensed home healthcare providers, offering services including medical consultations, nursing, physiotherapy, elderly care, laboratory testing and diagnostic imaging.
• The Aleppo-based startup currently operates in Aleppo, Damascus and Hama, with plans to expand into four additional Syrian governorates by the end of 2027.
• The funding will support the development of its technology infrastructure, expansion of its healthcare provider network and team, and the transition from its minimum viable product (MVP) to a full mobile application scheduled for public launch in November 2026.

Press release:

Syrian healthtech startup Alo Hakeem has closed a $165,000 Pre-Seed funding round led by EBLA Ventures as it prepares to launch its mobile application and expand access to home healthcare services across Syria.

The company did not disclose the identities of other participating investors or its valuation.

Founded in 2025 by Abdullatif Al-Baroudi and Albaraa Abdulsalam, Alo Hakeem operates a digital platform connecting patients and families with licensed healthcare professionals who provide medical services at home.

The startup aims to address challenges facing patients seeking reliable home healthcare while providing healthcare professionals with a more structured system for delivering services.

Its offerings include home medical consultations, nursing, physiotherapy, elderly care, laboratory testing and diagnostic imaging. The platform coordinates appointments and connects patients with healthcare providers through its website and customer support operations.

Headquartered in Aleppo, Alo Hakeem currently serves patients in Aleppo, Damascus and Hama, with plans to enter four additional Syrian governorates by the end of 2027.

The company initially financed its operations independently, developing a minimum viable product and testing its service model through direct engagement with patients and medical professionals.

During its early development, Alo Hakeem participated in the ScaleUp 2025 programme and received mentorship through ChangeMakers, a programme run by Maynger Ventures, and Thimar, an initiative supporting Syrian startups in preparing for investment.

According to the company, the new funding will support its transition from the MVP stage to a fully developed digital platform, with the official Alo Hakeem mobile application scheduled to launch publicly in November 2026.

The investment will also be used to strengthen its technology infrastructure, expand its network of licensed healthcare providers and develop its team as it enters new markets within Syria.

EBLA Ventures, which invests in and supports Syrian entrepreneurs, has worked with the startup during its early development and investment preparation.

The funding comes as technology startups seek to address gaps in Syria's healthcare system, particularly access to services outside hospitals and traditional medical facilities.

For Alo Hakeem, the next stage will centre on moving beyond its initial service model and building a platform capable of coordinating home healthcare across a wider geographical area.